Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0056 | 0.8445 | 0.8445 |
Trichomonas vaginalis | CMGC family protein kinase | 0.005 | 0.7047 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.005 | 0.7047 | 0.7047 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0063 | 1 | 1 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0018 | 0 | 0.5 |
Echinococcus granulosus | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0056 | 0.8445 | 0.8445 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 1 | 1 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0056 | 0.8445 | 1 |
Giardia lamblia | Kinase, CMGC MAPK | 0.005 | 0.7047 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0063 | 1 | 1 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0018 | 0 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0063 | 1 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0063 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0018 | 0 | 0.5 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.005 | 0.7047 | 0.8344 |
Trichomonas vaginalis | CMGC family protein kinase | 0.005 | 0.7047 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0063 | 1 | 1 |
Trypanosoma brucei | protein kinase, putative | 0.005 | 0.7047 | 1 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0018 | 0 | 0.5 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.005 | 0.7047 | 0.8344 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 1 | 1 |
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0052 | 0.7603 | 0.7603 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 1 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.005 | 0.7047 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0063 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 1 | 1 |
Brugia malayi | MAP kinase sur-1 | 0.005 | 0.7047 | 0.7047 |
Mycobacterium tuberculosis | Probable short-chain type dehydrogenase/reductase | 0.0056 | 0.8445 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.005 | 0.7047 | 1 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.005 | 0.7047 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.005 | 0.7047 | 0.7047 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0056 | 0.8445 | 1 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.005 | 0.7047 | 1 |
Schistosoma mansoni | 3-hydroxyacyl-CoA dehydrogenase | 0.0056 | 0.8445 | 0.8445 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0018 | 0 | 0.5 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.005 | 0.7047 | 1 |
Echinococcus granulosus | mitogen activated protein kinase | 0.005 | 0.7047 | 0.7047 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.005 | 0.7047 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.005 | 0.7047 | 1 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.005 | 0.7047 | 0.7047 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 1 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0063 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.005 | 0.7047 | 0.7047 |
Brugia malayi | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0056 | 0.8445 | 0.8445 |
Leishmania major | 3-oxoacyl-(acyl-carrier protein) reductase, putative | 0.0056 | 0.8445 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.005 | 0.7047 | 1 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.005 | 0.7047 | 0.7047 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.